The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)

A genomic clone encoding the protease (Pr) and the assembly protein (AP) of Kaposi's sarcoma-associated herpesvirus (KSHV) (also called human herpesvirus 8) has been isolated and sequenced. As with other herpesviruses, the Pr and AP coding regions are present within a single long open reading frame. The mature KSHV Pr and AP polypeptides are predicted to contain 230 and 283 residues, respectively. The amino acid sequence of KSHV Pr has 56% identity with that of herpesvirus salmiri, the most similar virus by phylogenetic comparison. Pr is expressed in infected human cells as a late viral gene product, as suggested by RNA analysis of KSHV-infected BCBL-1 cells. Expression of the Pr domain in Escherichia coli yields an enzymatically active species, as determined by cleavage of synthetic peptide substrates, while an active-site mutant of this same domain yields minimal proteolytic activity. Sequence comparisons with human cytomegalovirus (HCMV) Pr permitted the identification of the catalytic residues, Ser114, His46, and His134, based on the known structure of the HCMV enzyme. The amino acid sequences of the release site of KSHV Pr (Tyr-Leu-Lys-Ala*Ser-Leu-Ile-Pro) and the maturation site (Arg-Leu-Glu-Ala*Ser-Ser-Arg-Ser) show that the extended substrate binding pocket differs from that of other members of the family. The conservation of amino acids known to be involved in the dimer interface region of HCMV Pr suggests that KSHV Pr assembles in a similar fashion. These features of the viral protease provide opportunities to develop specific inhibitors of its enzymatic activity.

[1]  S. Plafker,et al.  Human cytomegalovirus capsid assembly protein precursor (pUL80.5) interacts with itself and with the major capsid protein (pUL86) through two different domains , 1997, Journal of virology.

[2]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Cole.  Characterization of human cytomegalovirus protease dimerization by analytical centrifugation. , 1996, Biochemistry.

[4]  C. Craik,et al.  Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines , 1996, Journal of virology.

[5]  I. Kuntz,et al.  Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Bonneau,et al.  A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease , 1996, Nature.

[7]  J. Culp,et al.  Unique fold and active site in cytomegalovirus protease , 1996, Nature.

[8]  R. Kurumbail,et al.  Three-dimensional structure of human cytomegalovirus protease , 1996, Nature.

[9]  David A. Matthews,et al.  Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic Triad , 1996, Cell.

[10]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[11]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[12]  W. Zhong,et al.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Kay,et al.  Cloning, expression and characterization of the proteinase from human herpesvirus 6 , 1996, Journal of virology.

[14]  L. Kuo,et al.  Active Human Cytomegalovirus Protease Is a Dimer (*) , 1996, The Journal of Biological Chemistry.

[15]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[16]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[17]  A. Kwong,et al.  Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein , 1996, Journal of virology.

[18]  E. Cesarman,et al.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.

[19]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.

[20]  P. Darke,et al.  Activation of the Herpes Simplex Virus Type 1 Protease (*) , 1995, The Journal of Biological Chemistry.

[21]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[22]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[23]  P. Biberfeld,et al.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma , 1995, Nature Medicine.

[24]  W. Gibson,et al.  Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad , 1995, Journal of virology.

[25]  W. Gibson,et al.  Assemblin, a herpes virus serine maturational proteinase and new molecular target for antivirals , 1995 .

[26]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[27]  B. Dunn,et al.  A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate. , 1995, Analytical biochemistry.

[28]  D. Ganem.  AIDS: Viruses, cytokines and Kaposi's sarcoma , 1995, Current Biology.

[29]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[30]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[31]  M. Kaplan,et al.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.

[32]  C. Craik,et al.  Structural basis of substrate specificity in the serine proteases , 1995, Protein science : a publication of the Protein Society.

[33]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[34]  C. Mapelli,et al.  In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease. , 1994, European journal of biochemistry.

[35]  K. Duffin,et al.  Activity of two-chain recombinant human cytomegalovirus protease. , 1994, The Journal of biological chemistry.

[36]  F. Rixon,et al.  The herpes simplex virus gene UL26 proteinase in the presence of the UL26.5 gene product promotes the formation of scaffold-like structures. , 1994, The Journal of general virology.

[37]  Simon C Watkins,et al.  The size and symmetry of B capsids of herpes simplex virus type 1 are determined by the gene products of the UL26 open reading frame , 1994, Journal of virology.

[38]  J. Loutsch,et al.  Cloning and sequence analysis of murine cytomegalovirus protease and capsid assembly protein genes. , 1994, Biochemical and biophysical research communications.

[39]  G. Fields,et al.  Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). , 1994, The Journal of biological chemistry.

[40]  W. Newcomb,et al.  The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth , 1994, Journal of virology.

[41]  H. Hsiung,et al.  Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites , 1994, Journal of virology.

[42]  F. Rixon,et al.  Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a. , 1994, The Journal of general virology.

[43]  R. Colonno,et al.  Identification of the serine residue at the active site of the herpes simplex virus type 1 protease. , 1994, The Journal of biological chemistry.

[44]  D. R. Thomsen,et al.  Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins , 1994, Journal of virology.

[45]  C. Mapelli,et al.  In vitro activity of the herpes simplex virus type 1 protease with peptide substrates. , 1993, The Journal of biological chemistry.

[46]  W. Gibson,et al.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine , 1993, Journal of virology.

[47]  L. Babe,et al.  Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases , 1992, Protein science : a publication of the Protein Society.

[48]  Albrecht,et al.  Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.

[49]  B. Roizman,et al.  Differentiation of multiple domains in the herpes simplex virus 1 protease encoded by the UL26 gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  W. Gibson,et al.  A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Roizman,et al.  The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate , 1991, Journal of virology.

[52]  R. Gallo,et al.  Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.

[53]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[54]  C. Craik,et al.  Substrate specificity of trypsin investigated by using a genetic selection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[55]  W. Gibson,et al.  Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end , 1990, Journal of virology.

[56]  V. Beral,et al.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.

[57]  F. Rixon,et al.  The products of herpes simplex virus type 1 gene UL26 which are involved in DNA packaging are strongly associated with empty but not with full capsids. , 1988, The Journal of general virology.

[58]  S. Bachenheimer,et al.  Characterization of intranuclear capsids made by ts morphogenic mutants of HSV-1. , 1988, Virology.

[59]  W. Rutter,et al.  The catalytic role of the active site aspartic acid in serine proteases. , 1987, Science.

[60]  W. Gibson,et al.  Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles , 1985, Journal of virology.

[61]  F. Rixon,et al.  Identification and Characterization of a Herpes Simplex Virus Gene Product Required for Encapsidation of Virus DNA , 1983, Journal of virology.

[62]  W. Gibson.  Structural and nonstructural proteins of strain Colburn cytomegalovi , 1981 .

[63]  B. Roizman,et al.  Proteins Specified by Herpes Simplex Virus VIII. Characterization and Composition of Multiple Capsid Forms of Subtypes 1 and 2 , 1972, Journal of virology.

[64]  E. Kaiser,et al.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.

[65]  P. Spear,et al.  Proteins spcified by herpes simplex virus. II. Viral glycoprotins associated with cellular membranes. , 1970, Journal of virology.

[66]  A. Berger,et al.  On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. , 1968, Biochemical and biophysical research communications.

[67]  R. Grant,et al.  Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. , 1996, The Journal of infectious diseases.

[68]  F. Rixon,et al.  Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame. , 1992, Virology.

[69]  M. Hutt.  The epidemiology of Kaposi's sarcoma. , 1981, Antibiotics and chemotherapy.

[70]  O'Callaghan Dj,et al.  Molecular anatomy of herpesviruses: recent studies. , 1976 .

[71]  C. Randall,et al.  Molecular anatomy of herpesviruses: recent studies. , 1976, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.